AAPL 207.5 +0.52 (+0.25%)MSFT 125.42 +0.48 (+0.38%)FB 183.67 +0.21 (+0.11%)ZNGA 5.62 +0.1 (+1.81%)NVDA 190.7 -0.66 (-0.34%)WBA 53.19 -0.53 (-0.99%)GOOG 1264.39 -1.93 (-0.15%)PIH 5.25 -0.05 (-0.94%)
AAPL 207.5 +0.52 (+0.25%)MSFT 125.42 +0.48 (+0.38%)FB 183.67 +0.21 (+0.11%)ZNGA 5.62 +0.1 (+1.81%)NVDA 190.7 -0.66 (-0.34%)WBA 53.19 -0.53 (-0.99%)GOOG 1264.39 -1.93 (-0.15%)PIH 5.25 -0.05 (-0.94%)

Discounted Cash Flow (DCF) Analysis Levered

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

51.52 0.56 Healthcare
All | Free Cash Flow | Weighted Average Cost Of Capital | Build Up Free Cash | Terminal Value | Intrinsic Value | Results |

Free Cash Flow IFRX Quote InflaRx N.V

Weighted Average Cost Of Capital IFRX Quote InflaRx N.V

Share Price $ 51.52
Diluted Shares Outstanding 23
Cost of Debt
Tax Rate -
After-tax Cost of Debt -
Risk Free Rate
Market Risk Premium
Cost of Equity -2.88
Total Debt 0.00
Total Equity 463.68
Total Capital 463.68
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash Flow IFRX Quote InflaRx N.V

Terminal Value IFRX Quote InflaRx N.V

Growth in perpetuity method:
Long term growth rate
WACC (%) -2.9
Free cash flow (t+1) 0.00
Terminal Value 0.00
Present Value of Terminal Value 0.00

Intrinsic Value IFRX Quote InflaRx N.V

Enterprise Value -
Net Debt -123
Equity Value -
Shares Outstanding 9
Equity Value Per Share -

Results Levered DCF IFRX Quote InflaRx N.V